Literature DB >> 7131237

Determination of oxycodone metabolites in urines and feces of several mammalian species.

T Ishida, K Oguri, H Yoshimura.   

Abstract

Determination of oxycodone metabolites excreted in urines and feces of several mammalian species was studied by use of the tritium labeled compound. It was found that the radioactivity was excreted more in the urines than in the feces in rabbits, guinea pigs and mice, but not in rats, who eliminated it equally into the urines and feces. Most of the radioactivity was excreted in 48 h after the administration. Seven metabolites, oxymorphone, 6 alpha-oxycodol, 6 beta-oxycodol, 7 beta-hydroxy-6 beta-oxycodol, noroxycodone, oxycodone N-oxide, and 6 alpha-oxycodol, N-oxide, as well as well as unchanged oxycodone, were found to be excreted into urines of rabbits in both free and conjugated forms except two N-oxides, which were found only in the free form. It was discussed that analgesic effect of oxycodone would mainly be attributable to the oxycodone itself, but not to the metabolites.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7131237     DOI: 10.1248/bpb1978.5.521

Source DB:  PubMed          Journal:  J Pharmacobiodyn        ISSN: 0386-846X


  3 in total

1.  Determination of oxycodone, noroxycodone and oxymorphone by high-performance liquid chromatography-electrospray ionization-tandem mass spectrometry in human matrices: in vivo and in vitro applications.

Authors:  Wenfang B Fang; Michelle R Lofwall; Sharon L Walsh; David E Moody
Journal:  J Anal Toxicol       Date:  2013-06-05       Impact factor: 3.367

2.  The pharmacokinetics and metabolism of oxycodone after intramuscular and oral administration to healthy subjects.

Authors:  R Pöyhiä; T Seppälä; K T Olkkola; E Kalso
Journal:  Br J Clin Pharmacol       Date:  1992-06       Impact factor: 4.335

3.  Bioavailability of oxycodone by mouth in coronary artery bypass surgery patients - a randomized trial.

Authors:  Antti Valtola; James D Morse; Pawel Florkiewicz; Heidi Hautajärvi; Pasi Lahtinen; Tadeusz Musialowicz; Brian J Anderson; Veli-Pekka Ranta; Hannu Kokki
Journal:  J Drug Assess       Date:  2020-07-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.